It is to bring to your notice that, the Board of Combat Drugs Limited at its Board meeting on 20th December, 2019, approved the Allotment of 21,00,000 Equity Shares of face value of Rs.10/- each at a premium of Rs.30/- each (i.e; at Rs.40/including premium) for consideration other than cash to the shareholders of Decipher Software Solutions ('DSSLLC'), on Preferential basis (vide swap of shares) pursuant to the acquisition of 100% stake in DSSLLC in accordance with section 62 of the Companies Act, 2013 pursuant to the Swap Arrangement and in accordance with the Chapter V of SEBI (ICDR) Regulations, 2018. Pursuant to this allotment, the paid-up capital of the Company has been increased from Rs. 8,00,00,000/- to Rs. 10,10,00,000/-. The meeting commenced at 11:00 am and concluded at 12:45 pm. This is in compliance with Regulation 30 of SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015.